Data / Form D filings / Q-Immune, Inc.
Q-Immune, Inc.: Form D filing
Q-Immune, Inc., a biotechnology company in Seattle, WA, filed a Form D with the SEC in 2026. The latest, on September 28, 2026, reports $25,000 sold of a $1 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2607 NE 100TH ST, Seattle, WA, 98125
- Phone
- (206) 914-1995
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Washington
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2155816
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | New notice | $1,000,000 | $25,000 | $975,000 | 1 | Sep 24, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Cameron McCann | Executive Officer, Director, Promoter | |
| Stephen Paucha Smith | Executive Officer, Director |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
- Automera US Inc. $1 million · Aug 7, 2026
Every Form D from the week of Sep 28, 2026 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Q-Immune, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.